Daiichi Sankyo
Daiichi Sankyo Company Limited (第一三共株式会社, Daiichi Sankyō Kabushiki-gaisha) (TYO: 4568) is a joint holding company established in 2005 by Sankyo Co., Ltd. (三共株式会社, Sankyō Kabushiki-gaisha) and Daiichi Pharmaceutical Co., Ltd. (第一製薬株式会社, Daiichi Seiyaku Kabushiki-gaisha), which are pharmaceutical companies based in Japan. Its main offices are located in Chūō-ku, Tokyo.
Major products of Daiichi Sankyo Group
Sankyo
- Benicar(olmesartan medoxomil)
- Mevalotin (pravastatin)
- Loxonin (loxoprofen)
- Olmetec (olmesartan)
- Captopril
- Zantac (ranitidine)
- WelChol (colesevelam HCl)
Daiichi Pharmaceutical
- Cravit (levofloxacin)
- Evoxac (cevimeline)
- FloxinOtic (ofloxacin)
External links
 | This article about a Japanese corporation- or company-related topic is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |